Walleye Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Walleye Capital’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,507	Closed	-$374K	–	5167
2023 Q1	$374K	Buy	+15,507	New	+$195K	0.01%	1948
2021 Q2	–	Sell	-103,823	Closed	-$1.09K	–	1574
2021 Q1	$1.09K	Buy	+103,823	New	+$1.46M	0.06%	276

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Walleye Capital's PRVB Position: Q2 2023 in Review

Walleye Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 15,507 shares — an estimated $374K sold.

Walleye Capital first reported a position in PRVB in Q1 2021 and held it in 2 quarters. The position peaked at $374K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Walleye Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Walleye Capital sold 15,507 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $374K.
Walleye Capital first reported a position in Provention Bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
Walleye Capital's Provention Bio, Inc. Common Stock position peaked at $374K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Walleye Capital's 13F filing for Q2 2023, filed 14 Aug 2023.